Brief: Bone Therapeutics Enters Into Exclusive Reverse Merger Discussions With Medsenic

Biosenic SA

12/05/2022 06:13

May 12 (Reuters) - Bone Therapeutics SA  BOTHE.BR :
    * BONE THERAPEUTICS ENTERS INTO EXCLUSIVE REVERSE MERGER
DISCUSSIONS WITH MEDSENIC
    * ONE THERAPEUTICS AND MEDSENIC AIM TO REACH AN AGREEMENT IN
COURSE OF Q2/Q3 2022
    * HAS ENTERED INTO A NON-BINDING TERM SHEET AND EXCLUSIVE
DISCUSSIONS FOR A PERIOD OF THREE MONTHS WITH SHAREHOLDERS OF
MEDSENIC
    * OBJECTIVE OF DISCUSSIONS IS TO EXPLORE BENEFITS OF A
POTENTIAL
REVERSE MERGER OR A SIMILAR TRANSACTION
    * PARTIES EXPECT THAT IMMEDIATELY AFTER CLOSING OF BUSINESS
COMBINATION, APPROXIMATELY 80 PERCENT OF TOTAL OUTSTANDING SHARE
CAPITAL OF BONE THERAPEUTICS SHALL BE HELD BY SHAREHOLDERS OF
MEDSENIC

Source text for Eikon:  ID:nGNE5G8gfd 
Further company coverage:  BOTHE.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))